On March 2, 2022, the European Commission’s Group of Chief Scientific Advisors (GCSA) released a scientific opinion providing recommendations on how to improve the existing cancer screening programmes for breast, colorectal and cervical cancer.
Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, said:
“Saving lives by improving cancer prevention and early detection is one of the key aims of the EU Mission on Cancer. Research and innovation advance our understanding of all phases of cancer and pave the way to improve diagnosis, treatment and care interventions. This Scientific Opinion provides key insights and recommendations and it thus contributes significantly to this goal.”
The advisors stressed the importance of making existing screening programmes more accessible by overcoming individual and societal barriers against participation. Taking part in cancer screening should be made easy for those who would benefit from it the most.
We were happy to find that PRESCRIP-TEC has been following these recommendations from the beginning of the project. Our main goal is to increase the adoption of cervical cancer screening by improving availability, accessibility, acceptability and quality of services in resource-poor or hard-to-reach areas of Bangladesh, India, Uganda and Slovakia.
To achieve our goal, we base our work on four main lines of action:
- Informing and sensitising women about the screening process to promote accessibility and acceptability of the screening programs.
- Facilitating self HPV testing at home to make things easier for women living in remote areas.
- Introducing artificial intelligence in the gynaecological examination to improve diagnosis precision and to make work easier for health workers.
- Providing immediate assistance to women who need treatment of cervical lesions.
Access to more information about this topic here.
For more information about PRESCRIP-TEC visit this page.
